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ABSTRACT 
Introduction: Iron deficiency anemia is an important public health problem in 
Sudan. Between 1994 and 1995, the WHO survey observed a high prevalence 
(84.6%) of hemoglobin concentrations below 110.0g/l in the universe of children 
between 6 month and 5 years. 
OBJECTIVE: Evaluation the effect of weekly iron supplementation on 
hemoglobin status in preschool children in Dongola city. 
Materials and methods: This was an interventional study conducted in three 
kindergartens in the town of Dongola – Sudan, in which children were 
examined at two different periods: at the beginning of treatment (T1); and 
after three months of iron supplementation (T2). The iron supplement (6 
mg/kg) was provided on a weekly basis to all children (n=72) 3 to 5 years 
old regardless of the initial Hb reading during three months at the institution 
by the researcher to control hemoglobin levels. 
 Hemoglobin measurements were obtained using a portable digital 
colorimeter–(lab- tech, made in India, SR.NO.15605/05/08) 
Cynomethahemoglobin. 
Results: The prevalence of anemia in study group was 60% .A significant 
improvement was observed in the hemoglobin levels of the children 
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regardless the age and initial hemoglobin levels. The hemoglobin 
concentration of these children improved an average of 0.67 g/l after each 
dose of iron sulfate. At the end of three months there was an average gain 
of 8 g/l, and prevalence of anemia reduced by 1/2.  
Conclusion: the weekly iron supplementation reduced the prevalence 
of anemia and increased the hemoglobin levels of preschoolers of Dongola 
city. 
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  اﻟﻤﻠﺨﺺ
ﻋﻦ ﻧﻘﺺ اﻟﺤﺪﻳﺪ ﻣﻦ اآﺒﺮ اﻟﻤﺸﺎآﻞ اﻟﺼﺤﻴﺔ ﻟﺪى  ﻳﻌﺘﺒﺮ ﻓﻘﺮ اﻟﺪم اﻟﻨﺎﺗﺞ :اﻟﻤﻘﺪﻣﺔ
 4991ﻓﻲ دراﺳﺔ اﺟﺮﻳﺖ ﺑﻮاﺳﻄﺔ ﻣﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﻟﻤﻴﺔ ﻣﺎﺑﻴﻦ .اﻻﻃﻔﺎل  ﻓﻰ اﻟﺴﻮدان
ﺷﻬﻮر اﻟﻰ 6ﻣﻦ ﻋﻤﺮ )اوﺿﺤﺖ اﻟﺪراﺳﺔ ان ﻧﺴﺒﺔ اﻻﻧﻴﻤﺎ وﺳﻂ اﻻﻃﻔﺎل  5991و
  %. 48ﺑﻠﻐﺖ ( ﺳﻨﻮات5
ﺘﻮى اﻟﻬﻴﻤﻮﻗﻠﺒﻴﻦ ﻓﻲ ﻋﻠﻰ ﻣﺴ  ﺗﻘﻴﻴﻢ  ﻓﻌﺎﻟﻴﺔ اﻟﺠﺮﻋﺎت  اﻟﺤﺪﻳﺪ اﻷﺳﺒﻮﻋﻴﺔ: اﻟﻐﺮض 
  دون اﻟﺨﺎﻣﺴﺔ ﻷﻃﻔﺎلا
  :اﻻدوات واﻟﻄﺮﻳﻘﺔ
ﺣﻴﺚ ﺗﻢ إﻋﻄﺎء ﺟﺮﻋﺔ .اﻟﺪراﺳﺔ أﺟﺮﻳﺖ ﻓﻲ ﺛﻼﺛﺔ ﻣﻦ رﻳﺎض اﻷﻃﻔﺎل ﺑﻤﺪﻳﻨﺔ دﻧﻘﻼ  
ﺑﻐﺾ اﻟﻨﻈﺮ ﻋﻦ ﻧﺴﺒﺔ اﻟﻬﻴﻤﻮﻗﻠﻮﺑﻴﻦ   (آﺠﻢ/ﻣﻠﺠﻢ6)أﺳﺒﻮﻋﻴﺔ ﻣﻦ آﺒﺮﻳﺘﺎت اﻟﺤﺪﻳﺪ 
  .ﻃﻔﻞ ﻟﻤﺪة ﺛﻼﺛﺔ اﺷﻬﺮ 27ﻟﻌﺪد اﻻوﻟﻲ
وﻣﻦ ﺛﻢ ﺗﻢ ﻓﺤﺺ . ﻟﻸﻃﻔﺎل ﺑﻮاﺳﻄﺔ اﺧﺼﺎﺋﻰ أﻃﻔﺎل ﺗﻢ إﺟﺮاء آﺸﻒ آﺎﻣﻞ 
  . ﺑﻮاﺳﻄﺔ دﻳﺠﺘﺎل آﻠﻮروﻣﻴﺘﺮ)2T( )وﺑﻌﺪ اﻟﺠﺮﻋﺎت اﻷﺳﺒﻮﻋﻴﺔ(  1T)اﻟﻬﻴﻤﻮﻗﻠﻮﺑﻴﻦ ﻗﺒﻞ
  :اﻟﻨﺘﻴﺠﺔ
  :هﺬﻩ اﻟﺪراﺳﺔ أﻇﻬﺮت ﺑﻌﺾ اﻟﻨﺘﺎﺋﺞ اﻟﻤﻬﻤﺔ  
  %.06ﻧﺴﺒﺔ اﻷﻧﻴﻤﻴﺎ وﺳﻂ أﻃﻔﺎل اﻟﺪراﺳﺔ آﺎﻧﺖ  -
  .ﻟﺘﺮ ﺑﻌﺪ ﺛﻼﺛﺔ اﺷﻬﺮ/ﺟﻢ 8ﺑﺰﻳﺎدة ﻗﺪرهﺎ ﺗﺤﺴﻦ واﺿﺢ ﻓﻲ ﻧﺴﺒﺔ اﻟﻬﻴﻤﻮﻗﻠﻮﺑﻴﻦ  -
ﻣﻦ )أﻳﻀﺎ أﻇﻬﺮت اﻟﺪراﺳﺔ ﻧﺘﻴﺠﺔ ﻣﻬﻤﺔ ﺟﺪا هﻲ اﻧﺤﺪار ﻧﺴﺒﺔ اﻷﻧﻴﻤﻴﺎإﻟﻰ اﻟﻨﺼﻒ -
   %(.5.82إﻟﻰ% 75
   :اﻟﺨﻼﺻﺔ
اﻟﺠﺮﻋﺎت اﻟﺤﺪﻳﺪ اﻻﺳﺒﻮﻋﻴﺔ  ﻟﻼﻃﻔﺎل دون اﻟﺨﺎﻣﺴﺔ ﺗﻘﻠﻞ ﻣﻦ ﻧﺴﺒﺔ اﻻﻧﻴﻤﻴﺎ وﺗﺬﻳﺪ ﻧﺴﺒﺔ 
 .اﻟﻬﻴﻤﻮﻗﻠﻮﺑﻴﻦ ﻟﺪﻳﻬﻢ 
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Chapter One  
I‐ INTRODUCTION AND LITRITURE REVIEW 
I -1-Definition 
Anemia is defined as a pathological process in which hemoglobin (Hb) 
concentration in red cells is abnormally low, considering variations as to 
age, gender, sea-level altitude, as a result of several situations such as 
chronic infections, hereditary blood conditions, deficiency of one or more 
essential nutrients that are necessary for the formation of hemoglobin 
e.g.: folic acid, B12, B6 and C vitamins, and proteins(1). Therefore, there 
is no doubt that iron deficiency is the cause of most anemias. It is called 
iron deficiency anemia(IDA). 
I-2-The Dangers of IDA 
IDA in children ages one month-5years can result in behavioral(2), 
cognitive,  psychometric(3-5) deficits and decreased grows rate(6, 7), as 
well as impaired  immune system thus increasing the susceptibility of 
infection even in mild cases(8). These impairments can lead to decreased 
motor activity, social interaction, and attention to tasks, just to mention a 
few. Simply put, the child’s body and brain are not getting enough 
oxygen to run well, so it begins running poorly on all levels. If the 
problem is not addressed and reversed, the developmental delays can 
persist past school-age and may even result in irreversible deficits. The 
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danger of irreversible developmental delays due to a temporary 
nutritional deficiency emphasizes the importance of prevention, 
especially since the risk of IDA during this period depends largely on 
diet. IDA can also contribute to lead poisoning because it heightens the 
gastrointestinal tract’s ability to absorb heavy metals. 
I-3-Some aspects about iron metabolism 
There are two forms of iron: ferrous iron (Fe++) and ferric iron (Fe+++). 
The iron content in the human body is equivalent to 3 to 5g; part of it is 
used for metabolic and oxidative functions (70% to 80%), and the rest is 
stored as ferritin and hemosiderin in the liver, spleen and bone marrow 
(20% to 30%). 
Over 65% of the iron content is found in hemoglobin, whose major 
function is to transport oxygen and carbon dioxide. In hemoglobin, an 
atom of divalent iron is found at the center of the tetrapyrrole core 
(protoporphyrin IX), forming the heme nucleus. Therefore, iron is 
essential for the formation of hemoglobin(9). 
In addition, iron is part of the composition of the myoglobin molecule of 
muscle tissue and acts as an enzyme reaction cofactor in the Kreb,s cycle, 
(responsible for the aerobic metabolism of tissues) and in the synthesis of 
purines, carnitine, collagen and brain neurotransmitters. Iron is also 
present in the composition of flavoproteins and heme proteins catalase 
3 
 
and peroxidase (found in erythrocytes and hepatocytes). These enzymes 
are responsible for the reduction of the hydrogen peroxide produced in 
the body(10).Today, iron is also involved in the conversion reactions of 
beta-carotene into the active form of vitamin A, a fact that partly explains 
the important interaction between these nutrients(11). 
I-4-Requirements and recommendations 
Since iron is an important micronutrient, the body has a very efficient 
mechanism to avoid its loss. This way, the iron content is maintained 
within certain limits with the aim of adequating its use. Even the iron that 
originates from red cells, taken from the circulatory system, whose half 
life is120 days, is reused. Daily iron losses are about 1 mg, mainly due to 
cell desquamation. In addition, small quantities are lost through urine, 
sweat and feces. Other situations such as menstruation, lactation and 
parasitoses may cause additional iron loss(9). 
The intestinal tract plays a very important role in the recycling 
mechanism of body iron, since absorption may change according to body 
needs, that is, when reserves are low, there is a significant increase in 
absorption, and when they are high, absorption is inhibited. 
As body iron requirements are associated with different stages of life, the 
rate of iron absorption by the intestinal tract is also related to age group. 
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For instance, a 12-month infant presents an absorption rate four times 
higher than others in different age groups(12). 
By considering these aspects, we may conclude that daily iron 
requirements are low and vary according to the stage of life. Therefore, 
considering an absorption rate of 10%, RDA (Recommended Dietary 
Allowances)(13) preconizes a daily 10-mg intake of elementary iron for 
infants aged between 6 months and 3 years; 12 to 15mg, for male and 
female adolescents, respectively; 10 mg for male and female adults after 
they stop menstruating, and 15 mg for women at reproductive age and 
nurturers. Pregnant women need a daily intake of 30 mg of iron. 
I-5-Food sources 
Iron is found in several foods of animal origin (all kinds of meat, milk, 
and eggs) and of vegetable origin (dark green vegetables, beans, soy 
beans, among others). However, it is necessary to clarify the capacity of 
the body of absorbing the available iron so that it can accomplish several 
functions, which determines its bioavailability(14). 
I-6-Absorption and transport 
Duodenal iron absorption depends on the nature of the iron complex that 
is present in the intestinal lumen, as well as on the presence of facilitating 
and inhibitory factors in the diet, in addition to organic reserves (15, 16). 
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Iron absorption can be classified as heme and nonheme absorption. The 
iron linked to the heme comes from foods of animal origin (hemoglobin, 
myoglobin and other heme proteins), which is well absorbed due to its 
high bioavailability and, in addition to improving the absorption of 
nonheme iron pool(15, 16). 
Nonheme iron is found in foods of vegetable origin under the form of 
ferric complex, which is partially reduced to the ferrous form during 
digestion, thus facilitating absorption, by the action of hydrochloric acid, 
bile and pancreatic juice(15, 16). 
After digestion, most of the iron forms an intraluminal deposit; therefore, 
its absorption is determined by facilitating factors (ascorbic acid, all kinds 
of meat, amino acids such as lysine, cysteine and histidine, citric and 
succinic acids, and sugars such as fructose) or inhibitors (phytates, found 
in cereals; phenolic compounds such as flavanoids, phenolic acids, 
polyphenols and tannins, found in black tea and maté, coffee and some 
soft drinks; calcium and phosphate salts, found in milk protein sources; 
egg fibers and protein)(15, 16). 
Therefore, we should take into consideration that there are iron-rich foods 
such as beans, which present low bioavailability due to the presence of 
phytates and fibers. On the other hand, meats have much lower iron 
contents, with high bioavailability. Milk is another interesting example of 
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bioavailability because mother’s milk and cow’s milk have basically the 
same amount of iron; mother’s milk, however, presents high absorption 
rate while cow’s milk presents low bioavailability due to its calcium and 
phosphate salt contents(17). 
The absorbed iron may be stored in the enterocyte cytoplasm in different 
ways: as ferritin conjugate, protein linkers (mobilferrin) or non protein 
linkers (amino acids), also in charge of transporting iron from the 
enterocyte into the basolateral membrane. Part of the iron that is stored 
this way may return to the intestinal lumen through desquamation. 
Transferrin transports iron through the blood stream. Each transferrin 
molecule joins two Fe+++ ions. This way, the measurement of serum 
transferrin saturation (% of serum iron ratio and the total capacity of iron 
linking) is considered an important indicator of body iron content. 
It is necessary to have specific receptors, which exist in great quantities in 
the tissues that need iron more urgently (bone marrow, liver, placenta), so 
that the body can use iron appropriately. Usually, about 70 to 90% of the 
iron is absorbed by the bone marrow for the production of hemoglobin. 
In the liver, spleen and bone marrow, iron may be deposited, bound to 
ferritin and hemosiderine up to twenty times beyond its normal 
amount(18). 
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Iron reserves formed during pregnancy are extremely important for new-
borns as these reserves will form an important source of endogenous iron, 
which, together with the exogenous iron from breast milk, will meet iron 
requirements up to 4-6 months of life. 
This way, the dosage of serum ferritin is an important indicator of body 
iron stores as it is directly proportional to the amount of body iron levels. 
I-7-Clinical signs and lab exams for the detection of iron deficiency 
and anemia 
Iron deficiency occurs at three stages. The first stage -iron depletion - 
occurs when iron content is not enough to meet body requirements. At the 
beginning, there is a reduction in iron deposition, characterized by serum 
ferritin below .012 mg/l, without functional changes. 
If the negative balance persists, the second stage begins- iron-deficient 
erythropoiesis - characterized by a reduction in serum iron, transferrin 
saturation below 16% and an increase in the free erythrocyte 
protoporphyrin level. At this stage, work capacity may be reduced. 
At the third stage - iron deficiency anemia – hemoglobin is below the 
standards for age and gender. This stage is characterized by the 
development of microcytosis and hypochromia. 
Iron depletion at the initial stages is substantially higher than anemia 
itself. The Pan-American Health Organization/World Health 
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Organization estimates that for each person with anemia there is at least 
another one with iron deficiency. Thus, a population in which 50% of 
children suffer from anemia - as is the case of Brazil, 100% actually have 
iron deficiency(19). 
The operational definition of anemia, in terms of hemoglobin levels, was 
established by the World Health Organization, adopting the level of 11.0 
g/dl for children under the age of six and pregnant women. For children 
aged between 6 and 14 years and non pregnant adult women, the level 
was 12 g/dl, and 13 g/dl for adult men(1). 
The clinical signs of anemia are not easily recognizable, and many times 
go unnoticed. These signs include paleness, anorexia, apathy, irritability, 
reduced attention and psychomotor deficiencies(20). 
I.8-Etiology of iron deficiency anemia 
Usually, anemia originates from blood loss and/or prolonged iron 
deficient diet, especially in periods in which requirements are high, as in 
the case of children and adolescents who have accelerated growth rate. In 
addition, pregnancy and lactation are periods in which there is a lot of 
iron requirement. 
The causes of iron deficiency anemia and iron deficiency may have their 
onset in the intrauterine life. Physiological reserves of iron (0.5g/kg in 
full-term new-borns) are formed during the last three months of 
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pregnancy, and together with the iron found in breastmilk, meet the 
demands of breast-fed infants until their sixth month of life. Therefore, 
we may conclude that prematurity, due to lack of time, and low weight at 
birth, due to reduced reserve, associated with early interruption of 
exclusive breast-feeding, are the most common causes that contribute to 
iron depletion in breastfed infants. During the first childhood, the 
problem is aggravated by incorrect feeding, especially at weaning, when 
breastmilk is usually replaced with iron-deficient foods. Cow’s milk is a 
good example, because, although it has the same iron content as 
breastmilk, its bioavailability is too low, and more often than not, mothers 
replace a meal with bottle feeding. 
Other aspects that aggravate and most times determine insufficient iron 
deposition have to be considered. These aspects include low 
socioeconomic and cultural level, poor sanitation conditions and difficult 
access to health services, and poor mother/child relationship(21, 22). 
Acute or chronic blood loss depletes body iron reserves and may cause 
pathologies such as gastro esophageal reflux, intolerance to cow’s milk 
protein and intestinal parasitoses(21). Parasites such as Ancylostoma 
duodenal or Necatoramericanus may cause considerable iron loss, either 
through the blood sucked by the parasite or through the bleeding caused 
by the lesion to the intestinal mucosa, also caused by the parasite. Other 
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parasites like Ascaris lumbricoides and Giardia lamblia cause bleeding as 
they compete for food. In general, the incidence of these parasites occurs 
in children who are older than 5 years. 
I.9-Management of IDA 
Iron deficiency anemia may present with minimal symptomatology and, 
hence, simply require iron supplementation and careful follow up. In the 
otherwise normal infant with mild/moderate anemia (hemoglobin 8-11 
g/dl), a trial of 3-6 mg/kg/day supplemental elemental iron is indicated 
for 1-2 months (23-26). The hematocrit or hemoglobin should be re-
evaluated in 1 month, and a presumptive diagnosis of iron deficiency 
anemia is suggested by an increase in hemoglobin by l g/dl or hematocrit 
by 3%. A reticulocyte count increased by at least 2% following initiation 
of treatment is additionally suggestive of iron deficiency anemia. 
Approximately 6 months following therapy, the hemoglobin or 
hematocrit should be assessed to document success of treatment and 
replenishment of iron stores(25). 
Suitable iron preparations for infants include ferrous sulfate drops and 
ferrous sulfate elixir. Ferrous sulfate elixir is appropriate for older infants 
and young children, and ferrous sulfate tablets for the older child and 
adolescent. Multivitamin preparation with added iron are suitable for 
providing maintenance amounts of supplemental iron or to treat mild iron 
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deficiency anemia but are not sufficiently therapeutic in cases of 
moderate/severe iron deficiency(23) 
Iron may be offered either as a divided or once daily dose(26) and is 
available over the counter (24). Iron supplements are often unpleasant 
tasting, therefore once daily dosing may enhance compliance and 
contribute to successful treatment. Administering the iron preparation 
into the back of the mouth in infants, using a straw in the older child, and 
rinsing or wiping the teeth after dosing may be recommended to avoid the 
side effect of dental staining (24, 26). Vitamin C enhances iron 
absorption, therefore, if taken with foods such as apple or orange juice 
absorption will be improved. Conversely, calcium interferes with 
absorption; therefore supplements should be taken between meals and not 
administered with milk. Dietary counseling to eliminate excessive milk 
intake and increase the intake of foods containing iron is recommended to 
augment the effects of supplementation (24, 27). 
Severe anemia (hemoglobin < 8 g/dl) and anemia that fails to respond to 
adequate iron supplementation will require more intensive investigation 
to confirm the diagnosis and offer appropriate management. Complete 
blood count with smear, indices including reticulocyte count, and markers 
including ferritin and iron should be evaluated if not already performed. 
Hemoglobin electrophoresis should also be considered to rule out the 
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presence of inherited hemoglobinopathies as the cause of the anemia, and 
consultation with a hematologist should be sought(25). 
I.10-Treatment of Cause 
        It is important to find out the etiological factor for iron deficiency, to 
prevent failure of therapy and recurrence of deficiency after treatment is 
stopped especially in older children who are likely to have a secondary 
IDA, as dietary deficiency is less likely at this age. Infants usually have 
poor dietary history especially lack of breast feed and improper weaning 
and/or bottle feeding and poor intake of iron containing food as a cause of 
iron deficiency. Promotion of exclusive breast feeding for first 4 to 6 
months. continuing breast feeding for as long as possible, thereafter with 
introduction of proper and age appropriate food items and prophylactic 
iron supplementation will prevent iron deficiency during infancy and 
early childhood(28). 
In older children diet modifications to improve total calorie intake and 
iron containing foods in diet will prevent iron deficiency. Treatment of 
worms, Giardiasis, bleeding from any site, recurrent infections are must 
treat the patient adequately besides iron. 
 
 
. 
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I.11-Iron Supplementation: Iron can be given orally or parentrally 
I.11.a-Oral Iron Therapy 
       Oral iron therapy is cost effective, safe, convenient, and well 
tolerated, preferred and advocated route of therapy. 
       It is given in the dose of 6 mg/kg of elemental iron in 2-3 divided 
doses. In one study, the initial dose of oral iron of 3mg/kg/day was also 
tried and later on increased to 6 mg/kg/ day when infants tolerated it(28). 
It is preferably given empty stomach or in between meals to facilitate 
better absorption. Doses higher than this are not recommended as the 
effect is not better but side effects are much more. Compliance in the first 
month of therapy is important as majority of iron absorption occurs 
during this period. It is continued for at least 2-3 months after 
hemoglobin becomes normal, to replenish stores(29). 
I.11.a.1-Iron Formulations 
There are two types of iron compounds available i.e. ionic (ferrous 
sulfate, fumarate, gluconate etc.) and nonionic(iron poly maltose complex 
and sucrose complex).Various forms of preparations are available 
including tablets, capsules, drops, syrups, sugar coated tablets, enteric 
coated tablets, slow release tablets and chewable tablets. 
(i) Uncoated tablets and sugar coated tablets are the least expensive 
formulations and disintegrate well in the stomach. However, they 
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become oxidized over time and hence lose efficacy especially in 
humid climate. 
(ii) Enteric coated tablets are somewhat more expensive. They have the 
added drawback that they disintegrate only partially when exposed to 
gastric juices. Only those which disintegrate invitro 0.1N 
hydrochloric acid within two hours should be used, thus allowing 
slow release of iron in the stomach. The rationale for slow release is 
that the iron absorption is related to the amount of iron present in the 
duodenum and jejunum while the frequency of gastro-intestinal side 
effects is directly proportionate to the amount. Hence, a smaller 
amount   of iron at a time (as compared to plain tablets) leads to 
fewer side effects with same efficacy. 
(iii) Liquid preparations are in the form of syrups and drops. These are 
expensive and deteriorate on storage, but are useful for administration 
to infants and children who cannot swallow tablets. They usually lead 
to temporary staining of teeth and tongue which disappears on 
discontinuation of the drug. 
(iv) Combination with other nutrients: Incorporation of ascorbic acid, 
vitamins and folic acid with iron increases the cost as well increases 
frequency of side effects and thus risks of non-compliance. 
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       Absorption of oral iron is enhanced by the presence of orange juice, 
meat, poultry products and inhibited by cereals, tea and milk. 
I.11.A. 2-Side Effects 
Major side effects of oral iron administration include heartburn, nausea, 
vomiting, abdominal cramps, diarrhea, constipation, staining of tongue 
and teeth, blackish discoloration of stools etc. Rarely, cases of acute iron 
poisoning can occur by taking accidental or suicidal overdose. But the 
side effects are less and well tolerated if proper counseling is done before 
starting the therapy. Of late, people have tried twice a week therapy 
which has proved to be equally effective if no better, with less side 
effects(29). Death has been reported after ingestion of as little as 650 mg 
of elemental iron. Absorption of 60mg/ kg is probably necessary for 
development of significant iron poisoning(30). 
I.11.B-Parentral Iron Therapy 
This includes both intramuscular and intravenous iron therapy. This 
therapy is somewhat more expensive and risky than oral with same 
recovery rate. Total dose of iron is calculated as (31). 
Total dose of elemental iron (mg) = weight of the child (kg)ൈ hemoglobin 
deficit(g/dl) ൈ4 
(i) Intramuscular preparations: Iron dextran complex and iron sorbitol 
containing 50 mg of elementral iron per ml are two available forms. 
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These are given deep into upper outer quadrant of the buttock and the 
skin should be laterally displaced before injection (2 track technique) to 
prevent staining of the skin. The dose of injectable iron is 1.5 mg (0.03 
ml)/ kg/ dose(31). 
(ii) Intravenous: There are two methods: 
 (a) Infusion of total dose diluted in ratio of 5 ml of iron dextran complex 
in 100 ml of normal saline. Initially flow rate should be kept at 20 
drops/ min for 5-10 minutes and if there are no adverse reactions, 
then rate can be increased,  
(b) Bolus injection of iron dextran diluted in 20 ml of normal saline can 
be given over10 to 20 minutes. Prior to administration, Sensitivity 
test and with a small dose should be performed. 
Side effects include local pain, flushing, pyrexia, malaise, vomiting, 
chills, arthralgia and anaphylaxis. Tender regional lymphadenitis and 
myalgias are delayed side effects. 
Because a rapid hematologic response can be confidently predicted in 
typical iron deficiency, blood transfusion is indicated only when the 
anemia is very severe or when superimposed infection may interfere with 
the response. It is not necessary to attempt rapid correction of severe 
anemia by transfusion. The procedure may be dangerous because of 
associated hypervolemia and cardiac dilatation. Packed or sedimented 
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RBCs should be administered slowly in an amount sufficient to raise the 
hemoglobin to a safe level at which the response to iron therapy can be 
awaited. In generally, severely anemic children with hemoglobin values 
less than 4g/ dl should be given only 2-3 ml/kg packed cells at any one 
time (furosemide may also be administered as a diuretic). If there is 
evidence of frank congestive heart failure a modified exchange 
transfusion using fresh packed RBCs should be considered although 
diuretics followed by slow infusion of packed RBCs may suffice(32). 
I.12-Prevention  
There are various approaches undertaken to prevent IDA, both at 
individual level and at the community level. They include diet 
modifications, iron supplementation, food fortification and control of 
recurrent infections(33, 34). 
. 
I.12.a-Diet Modification 
During infancy, exclusive breastfeeding for the first 4-6months of age 
will protect the baby from iron deficiency.  Thereafter breastfeeding must 
be continued for as long as 1.5-2 years. Equally important is the 
introduction of iron containing age appropriate food items.   Similarly 
preschool, school going children, adolescents and pregnant and lactating 
women should be encouraged to take iron rich food.   Hi case breast milk 
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is not available, iron fortified formula can be a better alternative than 
cow's milk provided one can afford it and prepare it properly and 
hygienically. Bottle feeding should be discouraged and strongly 
condemned by all means. Prolonged breastfeeding beyond 2years 
especially without introduction of age appropriate food can also lead to 
iron deficiency in children(33, 34). 
One can also increase the iron content of food by giving adequate calories 
in diet which itself will increase the iron content by 25-30 percent. One 
can encourage consumption of iron rich food like green leafy vegetables, 
spinach, jaggery and heme iron containing food like meat and fish. Heme 
iron is better available and also increases absorption of non-heme iron. 
Lastly, one can increase absorption of iron by adding Vitamin C 
containing food and by avoiding inhibitors like phytates and tannin 
(present in tea). Hence avoiding tea after meals and instead, consuming a 
portion of vitamin C containing citrus fruit after meals is a good 
custom(33, 34) 
. 
I.12.b-Control of infections 
Iron deficiency anemia and infections are inter-linked. Recurrent 
infections can lead to anemia of chronic infections adding to the burden 
of iron deficiency anemia. Hence, infections should be treated 
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energetically. Breast milk is the first vaccine against infection in an infant 
especially for decreasing morbidity and mortality due to diarrhea and 
Acute Respiratory Infections (ARI).Immunizations, sanitation and other 
public health measures will also help to decrease incidence of infections. 
Ancylostomiasis, trichuriasis and schistosomiasis can lead to GIT 
bleeding and iron deficiency. Giardiasis can also lead to malabsorption. 
All these infections should be treated in time to prevent iron deficiency. 
I.12.C-Iron Supplementation 
Prophylactic medicinal iron supplementation has be entried in high risk 
group including infants, preschool and school going children, 
adolescents, pregnant and lactating women. Such programs take the 
advantage of reaching masses through these captive high risk targets. 
Success of such programs will depend on adequate supplies, motivation, 
network of distribution, side-effects of iron and ultimate compliance of 
people. 
Full term babies should receive 2 mg of elemental iron/kg/ day starting 
from 5th month of age onwards and preterm babies 3-4 mg of elemental 
iron/ kg/ day depending on birth weight starting from 6-8 weeks of age. 
Preschool children can be reached through teachers. School children can 
be given the iron tablets at school. Pregnant and lactating women can be 
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reached at maternity hospitals, primary health centres and subcentres, 
family planning centres, immunization centres etc. 
Two types of Iron Folic Acid (IFA) tablets are used for this purpose. 
Adult tablet (greyish white) contains 300 mg of ferrous sulfate (100 mg 
of elemental iron) and 0.5 mg of folic acid. Pediatric tablet (orange or red 
colored smaller tablets) contains 60 mg of ferrous sulfate (20 mg of 
elemental iron) and 0.1 mg of folic acid. Both are sugar coated and are 
available in a tin containing 1000 tablets. To be meaningful and effective 
at least 100 day/ year of supplementation should be given. It is given as 
30 tablets per month for 3 months with 10 tablets extra at last month to 
make it 100 days course, for prophylaxis 1 tablet a day is used and for 
those with moderate to severe anemia (8 g/ dl in children or <10.0 g/ dl in 
adults) are given in one tablet twice a day for at least 100 days. 
I.12. D-Food Fortification 
These include micronutrient sachets, fortified cereal-based 
complementary foods, and fat-based spreads. All contain multiple 
micronutrients, although not necessarily the same ones. The fortified 
complementary foods and fat-based spreads also provide macronutrients 
because of their importance for improving other outcomes such as 
growth. Programs to distribute cereal-based supplements fortified with 
iron and other micronutrients(35, 36) and iron-fortified milk(37, 38) 
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through health services have been shown to be effective in reducing 
anemia. Some of these programs have also shown benefits to child 
nutrition beyond anemia reduction(39) Micronutrient-fortified fat-based 
spreads are also efficacious in reducing ID and well accepted by young 
children(40).  
They have also shown improved linear growth and motor 
development(41).  Micronutrient sachets are very efficacious in 
preventing and treating ID (42, 43) They appear to be highly acceptable 
to both mothers and children because of their ease of use and are effective 
in reducing anemia(44). 
I.13-Prevalence of iron deficiency anemia 
Iron deficiency and iron deficiency anemia are considered the major 
public health problems and the most common nutritional deficiency 
around the world(34) due to their high prevalence, effects on 
development and growth, resistance to infections and association with the 
mortality of infants younger than 2 years. 
Iron deficiency anemia is universally distributed. There is an estimate that 
25% of the world population are affected by iron deficiency; the 
population groups which are most affected are infants aged between 4 
and 24 months, school age  children, female adolescents, pregnant 
women and nurturing mothers(45).  
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Iron deficiency anemia affects 43% of preschool children all over the 
world, especially in developing countries, which present prevalence rates 
four times higher than those found in industrialized countries. This high 
prevalence is associated with poor sanitation conditions, low 
socioeconomic conditions and high morbidity among infants(46). 
In Sudan, the prevalence of anemia in preschool children can be 
extremely high. Between 1994 and 1995, the survey observed a high 
prevalence (84.6%) of hemoglobin concentrations below 110.0g/l  in the 
universe of children between 6 month and 5 years(47) . 
International reports suggested that, in populations with a high 
prevalence of anemia (>40%), direct supplementation was likely to be the 
preferred initial approach to control existing anemia, then to be 
complemented, and perhaps replaced, by supplementation or nutritional 
guidance for the prevention of anemia(34, 48). 
Unfortunately, supplementation using medication, although efficient for 
the control of iron deficiency, presents several practical problems, 
because the obligation of ingesting the medication every day leads to 
saturation of the intestinal mucosa(48) which, in turn, causes 
gastrointestinal problems and non-compliance before hemoglobin levels 
are normal. In addition, as anemia generally does not present apparent 
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clinical symptoms, patients forget to continue treatment for a prolonged 
period. 
An attempt to solve this deficiency resulted in the proposal of an 
intermittent medical treatment (weekly or twice weekly)could have as 
similar an effect on the hemoglobin status as daily iron supplementation, 
reducing the side effects(49) and the interaction of a daily iron dose with 
the absorption of other nutrients(50). 
A study conducted in china with preschool children shows that the 
administration of twice- weekly or weekly iron doses are as effective as 
daily supplementation with the benefit of markedly reduced incidence of 
side effects(51). Another studies conducted on young Indonesian children 
show that a twice- weekly dose has a similar  effects as daily dose(52) 
and on  Brazilian preschool children(3years to 5years) show that anemia 
reduced by 1/3(53), and also there was study conducted on Cambodia 
children show that the Prevalence of anemia decreased from 62% to 12% 
and from 57% to 26% in children, (5-11 )years of age, in two rural 
primary schools in Kampot province, Cambodia, after oral 
supplementation weekly with iron/folic acid tablets for 20 weeks and with 
vitamin A and mebendazole twice per year. In 12 – 15 year old children 
success was less marked(54). Also there was study conducted on Jordan 
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preschool children (2 – 6 years) by using  weekly iron supplementation 
show that  the hemoglobin increased by 2.12g/l(55). 
Other studies prevented but did not control the deficiency(56). WHO 
(1993) has promoted field studies in different environmental settings and 
in different population groups in order to evaluate the efficacy of 
intermittent iron supplementation as general strategy. 
On the other hand, anthropometrical z-scores indicators (weight- for-age, 
height for-age and weight – for height) did not differ for the two periods 
investigated in all above studies. 
The goal of this study was to evaluate the efficacy of a weekly iron 
supplementation on the hematological status of Sudanese preschool 
children (3 to 5 years) in Dongola city. 
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II.‐JUSTIFICATION 
- Anemia is recognized as a worldwide public health problem .it is 
estimated by the WHO that the prevalence of anemia defined by 
hemoglobin less than 11g/dl and this is about 33%. In Sudan 
(including north of Sudan) the prevalence of  anemia in children is 
about 84.6%(47).  
- Anemia is one of the major causes of  mortality in children under 
five years in Sudan 
- In children, iron deficiency anemia has been associated with 
psychomotor and cognitive abnormalities, poor school 
performance, and mental retardation. 
- This is the first study in Sudan targeting to solve this problem by 
using weekly iron supplementation. 
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III-OBJECTIVE 
III.1-General objective: 
Evaluation of the effect of weekly iron supplementation on 
hemoglobin status in preschool children in Dongola city. 
III.2-Specific objectives 
A- To determine the prevalence of anemia in the study group. 
B-To determine the impact of weekly iron supplementation on the 
improvement of anemia. 
C- To determine the impact of weekly iron supplementation on 
increasing in hemoglobin level. 
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CHAPTER (2) 
MATERIALS AND METHODS 
4.1. Materials 
4.1.1- Drugs: 
4.1.1.1- Saferon syrup: 
The Iron preparation which was used in the study was saferon syrup   
50mg/5ml - is a trade name of ferric polymaltose –made in India by 
Glenmark company and imported to Sudan by Raheeg company. 
4.1.1.2. Vitamin C Tablet: 
Vitamin C in form of tablet ( Remedeca company ,Cyprus) , imported to 
Sudan by Siho trading company. 
4.1.2-Instruments : 
4.1.2.1- A beam balance detecto scale and stadiometer. 
This an instrument was used to measure body weight of children. 
4.1.2.2: Sterile lancet and   digital colorimeter (lab-tech, made in India, 
RS. NO.15605/05/08) cynometha hemoglobin) 
 
 
 
28 
 
 
4.2- Methods  
4.2.1-Study design: 
This is a prospective and interventional study which will assess the effect 
of weekly iron supplementation on hemoglobin level  
4.2.2- Study area: 
This study was carried out in Dongola city, which is about 500km north 
of Khartoum, and is the capital of Northern state of Sudan. It has a 
population of approximately about 30,000 individuals. In Dongola city 
there are three hospitals, Dongola Academic Hospital, Military Hospital 
and Police Hospital and other two health centers. The Kindergartens in 
Dongola city is about 6 Kindergartens, three of them were accepted to 
participate in the study, and they are: 
1-Almuhandseen academic kindergarten: It is located in Dongola city and 
it is a private center, has about 50 children 
2-Modern educational kindergarten: Also it is private institute with about 
70 children 
3- Child care center:  It is a government center for child care. It has about 
100 children.  
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4.2.3-Study period: 
This study was carried out in kindergartens of Dongola city between 2009 
and 2010.   
4.2.4-Study population 
The target population are children who are 3years to 5years living in 
Dongola city who attend well kindergartens 
4.2.4.1-inclusion criteria: 
Children who are 3 to 5 years living in Dongola city who attend well 
kindergartens. Only children with written informed parental consent are 
recruited into the study. 
4.2.4.2-Exclusion criteria: 
• Children whose parents refused to participate in the research. 
• Children with chronic illness such as thalassemia and physical 
handicaps. 
• Children with chronic medication. 
4.2.4.3- Sampling:  
All the directors of kindergartens in the Dongola city were asked to 
participate in the research after the risks and objectives of the study were 
explained to them. Only three kindergartens were agreed to participate, 
and then the parents of the children between 3 and 5 years were invited to 
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participate in the  study signing the consent term, only about 72 child 
their parents  agreed to participate from the three kindergartens, 44 male 
(61%) and 28 female (39%). 
 
Fortunately all of them present on the day of the baseline survey and none 
of these children showed clinical signs of chronic diseases at medical 
examination by the pediatrian. 
Each individual has baseline as internal control. 
4.2.5- Measurement 
• First day demographic variables, sex, age, school, and class were 
extracted directly from the school record. 
• Second day  the body weight of children wearing school uniforms 
without belt and shoes and with empty pockets was measured using a 
beam balance detecto scale and stadiometer. 
• Every child in the sample received a physical examination by the 
pediatrian before (T1). Clinical abnormalities such as skin infections 
upper respiratory infections, or ear infections were treated and 
recorded, but the children with such medical problems were included. 
• It was decided to only measure hemoglobin as an indicator of iron 
status because previous studies in similar population groups had 
shown that iron deficiency was the main cause for low hemoglobin 
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concentrations(7, 52), and because the primary aim was to decrease 
the prevalence of low hemoglobin concentrations rather than to build 
iron stores. 
• Hemoglobin concentration(Hb) was determined in finger-prick blood 
in all children in the morning and the samples of blood were  kept in 
micro-containers containing EDTA and hemoglobin concentration 
was measured by well trained laboratory Technician using sterile 
lancet and  digital colorimeter (laboratory -tech, made in India, RS. 
NO.15605/05/08, cynometha hemoglobin), before starting the 
intervention (T1) and after the intervention (after the three months, the 
period of the intervention) (T2). 
• The cut-off point used to define anemia was a hemoglobin 
concentration of < 110.0g/l (1). 
4.2.6-Intervention 
After the initial hemoglobin and body weight of the  children were 
measured, every child was received the iron supplementation 
(6mg/kg/week) with vitamin C (50mg) to increase the absorption of iron  
every week for three month the period of the study. 
The calculation of the dose (6mg/kg/week) in volume solution according 
to the body weight: 
Each 1ml of saferon contains 10mg of ferric polymaltose. 
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E.g. Child weighing 10kg takes: 10ൈ6 = 60mg 
In volume: 60mg/10mg ൈ1ml = 6 ml 
The specific dose of iron (ml) and vitamin C was given to the child after 
breakfast to minimize the gastrointestinal side effect of iron. 
The kindergartens were visited on the next day of delivering the 
supplement to the children to ask the individuals responsible for 
kindergartens about their observations – side effects of the drug, increase 
or decrease appetite and activity of children, and on the remaining days of 
the week parent were instructed to report any side effects. 
After the end of the supplementation treatment, the nutritionist of the 
kindergarten- person who responsible for preparing the diet- and the 
mothers of children were advised to improve iron bioavailability in the 
center’s everyday meals by: 
a- Inclusion of sources of vitamin C (lemon, orange, raw vegetables like 
tomatoes) at main meals-lunch and dinner. 
b- Elimination, as much as possible, iron absorption inhibitors like tea 
and coffee during meals, or only offering them between meals. 
c- Availability of the vegetables and meat at lunch and dinner, 
encouraging their ingestion. 
33 
 
For the difficult of giving the whole children the iron dose at the same 
time, the children were divided into two groups: 
- Group (A), the first evaluation hemoglobin concentration in July 
2009(T1) , the second- after weekly iron supplementation-  in sept. 
2009 (T2).  
- Group (B) the first evaluation in jan. 2010(T1), the second- after 
weekly iron supplementation- in March. 2010(T2). 
- All data obtained from the study were recorded in specific book. 
4.2.7-Stastitcal analysis: 
         The statistical analysis of quantitative data was performed using 
statistical package for science (SPSS) software (t.test). 
 
4.2.8-Ethical issues 
- A letter of invitation providing information and requesting consent 
was sent to the parents of children who were in grades 3-5years. The 
letter includes all information about the study like advantages and 
disadvantages of weekly iron supplementation to the children, and also 
was  explained to the parent of children that he can stop when he want 
without any reasons . 
- Only children with written informed parental consent are recruited 
into the study. 
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- -Proposal for study was approved by the local committee for ethics in 
Research in Dongola.   
- Giving iron supplementation to children is a public health intervention 
that has been done in a lot of settings to prevent anemia and found to 
be safe. Children were closely monitored, and mothers were required 
to report any adverse reactions that they noticed. 
- Verbal informed consent was obtained from kindergartens and minster 
of education of north state of Sudan. 
- Blood sample taken from children in simple method without any risk 
to child and lab. Technician (they wear hands gloves to insure the 
safety). 
- At the end of the study those children who still anemic received 
treatment. 
 
 
 
 
. 
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Chapter Five  
RESULTS 
 Results:  
The greatest difficulty in caring out this intervention study was following 
up the children investigated. Despite the best efforts, some of them were 
lost because they had either moved or had become ill.  
Table 1: The distribution of male and female in the study population. 
Female Male No. of total  
28 (39%) 44 (61%) 72 
 
Table2– Number of children lost to follow up  
% Lost No at T2 No at T1 Initial 
Age(years) 
33.3% 9 18 27 3 
16% 4 21 25 4 
15% 3 17 20 5 
22% 16 56 72 Total 
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Table 3: Distribution of male and female in the studied population  
Gender  Number  Percent(%) 
Male  36 64% 
Female  20 36% 
 
Figure (2): Distribution of male and female in studied population 
 
Most of the study population were male, they were about 64% and  36% 
were female, as shows in figure 2 and table 3 above. 
38 
 
Table 4– hemoglobin values of preschool children in Dongola city 
who completed the study 
 Frequency Percent (%) 
Less than 95 7 12.5% 
95-109 25 44.6% 
More than 110 24 42.9% 
Total 56  
 
Figure 3: The hemoglobin values of preschool children in Dongola 
city in those who completed the study 
 
 
 
less than 95g/l
95‐109 g/l
more than 110g/l
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Anemia prevalence (hemoglobin <110 g/L) among all children at the start 
of the study was high,  ( 43 out of 72) , they represent about 60% .This 
situation, as well as ethical considerations explains the lack of a placebo 
group which would have been desirable to assess the specific impact of 
the intervention. But we considered that each individual has baseline as 
internal control. 
 At baseline the selection of the study population that classified into three 
groups:  normal (Hb equal or more than110g/dl), mild to moderate (Hb = 
95-109 g/dl) and severe anemic (Hb< 95g/dl). 
Table 4 and figure 3 represents the hemoglobin values of  children who 
were completed the study  and also it shows that the children with 
hemoglobin values less than 110 g/l were about 57.1% (32 out of 56).  
 
 
 
. 
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Table 5(a): Hemoglobin distribution among males and females in the studied group 
Hb1  Gender  
Male Female Total 
Less than 95 Count 7 2 9 
% within Hb1 77.8% 22.2% 100.0% 
% within gender 19.4% 10.0% 16.1% 
% of Total(56) 12.5% 3.6% 16.1% 
95-109 Count 13 10 23 
% within Hb1 56.5% 43.5% 100.0% 
% within gender 36.1% 50.0% 41.1% 
% of Total(56) 23.2% 17.9% 41.1% 
More than 110 Count 16 8 24 
% within Hb1 66.7% 33.3% 100.0% 
% within gender 44.4% 40.0% 42.9% 
% of Total(56) 28.6% 14.3% 42.9% 
Total Count 36 20 56 
% within Hb1 64.3% 35.7% 100.0% 
% within gender 100.0% 100.0% 100.0% 
% of Total(56) 64.3% 35.7% 100.0% 
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Also the study showed that the prevalence of anemia in female of the 
study group was about 60% and in male of that group was 55% as 
describe in table 5(a), table 5(b) and figure (4) above.  
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Table 6: The body weight of study group of children from 3 years to 
5years 
 
 Frequency Percent 
10.0 2 3.6 
11.00 1 1.8 
12.00 5 8.9 
13.00 10 17.9 
14.00 9 16.1 
15.00 5 8.9 
16.00 9 16.1 
17.00 5 8.9 
18.00 5 8.9 
19.00 1 1.8 
20.00 2 3.6 
21.00 2 3.6 
Total 56 100.0 
 
The above table shows that the body range from 10 kg to 21 kg for 
children from 3 to 5 years. 
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Table 7:  The average body weight of kindergartens children in 
Dongola city. 
Average wt(kg) Ideal body wt(kg) Age (years) 
13.3 14 3 
15 16 4 
17.7 18 5 
 
Figure 5: The average body weight of Dongola city preschoolers  
 
 
As shows in table 7 and figure 5 above the mean body weight of the study 
group is less than the ideal body weight for each age. The ideal body 
weight for 3 years is 14 kg, for 4 years is 16 kg and for 5 years is 18 kg. 
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Table 8 – The hemoglobin values in studied population after three 
months (Hb2). 
Hb2 g/l Frequency Percent 
Less than 95 2 3.6 
95-109 14 25.0 
More than 110 40 71.4 
Total 56  
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Figure 6 - The hemoglobin values in studied population after three months (Hb2) 
 
 
 
 
 
There was a clear and significant reduction in the prevalence of anemia in 
study population after the weekly iron supplementation period 
(%Hb<110.0g/l), the prevalence reduced  by half, since the beginning of 
the weekly treatment the prevalence of anemia was 57.1%  and at the end 
of study it reduced to 28.6%), as described in table 8 and figure 6. 
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Table 10:  Hemoglobin concentration (mean ±SD) g/l) at the beginning of 
study(Hb1), and after three month of intervention using medication 
considering the children’s initial hemoglobin in kindergartens in Dongola 
city( 2009-2010) 
Hb2-Hb1 Hb2mean(SD) Hb1 
mean(SD) 
No Initial Hb g/l 
17 106.4 89.4 7 Less than 95 
9.29 111.09 101.8 25 95 to < 110 
8.4 120.77 112.375 24 110 and more 
7.96 114.84(11.4) 106.87(11.0)56 Total 
* p. value = 0.005 
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Figure (8) presents of Hb1, Hb2 according to the children’s initial 
hemoglobin  
 
 
Table 9, table 10, figure 7 and figure 8 represent that the average 
hemoglobin concentrations for the two moments of the study. A 
comparison of hemoglobin mean from the beginning of the study (Hb1) 
and after the three months intervention (Hb2) showed a significant 
increase (p. value is 0.005) of 8.0 g/l, regardless of the child initial age 
and hemoglobin. 
5 years old Children had higher initial hemoglobin values- approximately 
5g/l more- than the two others age groups.  
Comparing hemoglobin means, before and after three months 
intervention with medication, there was a significant increase by 8 g/l (p 
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= .005). The mean hemoglobin concentration increased from 106.9 g/l to 
114.8 at the end of study. 
Also the study showed that there was a significant variation between the 
anemic children and non anemic one in the effect of medication on 
hemoglobin levels. This variation was doubled in children who were 
anemic to begin with (17 g/l), compared to non-anemic children (8.4 g/l). 
Those with Hb< 110 g/l at baseline achieved a mean increase of (9.29 g/l) 
at the end of weekly treatment with medication. Severely anemic children 
(Hb< 95 g/l) achieved a gain of (17 g/l) at the end of iron 
supplementation. By the end of the study, they obtained a mean of 106.4 
g/l, that is, lower than the cutoff point for anemia by only 3.6 g/l.  
Children with a hemoglobin concentration higher than or equal to 95 g/l 
had average increase of 8.8 g/l, equal to half the increment (17 g/l) in 
severe anemia. 
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Table 11: Presents male and female still anemic after the intervention 
   Gender  
Hb2 Male Female Total 
 Less than 95 Count 2 0 2 
% within Hb2 100.0% .0% 100.0% 
% within gender 5.6% .0% 3.6% 
% of Total 3.6% .0% 3.6% 
95-109 Count 9 5 14 
% within Hb2 64.3% 35.7% 100.0% 
% within gender 25.0% 25.0% 25.0% 
% of Total 16.1% 8.9% 25.0% 
More than 110 Count 25 15 40 
% within Hb2 62.5% 37.5% 100.0% 
% within gender 69.4% 75.0% 71.4% 
% of Total 44.6% 26.8% 71.4% 
 Total Count 36 20 56 
% within Hb2 64.3% 35.7% 100.0% 
% within gender 100.0% 100.0% 100.0% 
% of Total 64.3% 35.7% 100.0% 
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Figure 9: the prevalence of anemia after weekly medication on male and 
female 
 
 
As table 11and figure 9 show there was a variation in responsiveness of 
female and male to weekly iron supplementation, the prevalence of 
anemia in female was dropped from 60% to 25%, and from 55% to 31% 
in male. 
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The study also showed that  the number of children with hemoglobin 
concentration less than 95 g/l before the intervention was 7 children (12.5 
%), and this was reduced by1/4 became  2 children(3.6%) at the end of 
study. And the number of children with hemoglobin concentration 95 g/l 
and less than 110 g/l at the baseline was 25 (44.6 g/l) and at the end of 
intervention they were 14 (25%), reduced by the half. 
 On opposite hand there was an increase in the number of children with 
hemoglobin concentration more than 110 g/l from 24 children (42.8%) to 
40 children (71.4%). 
At the beginning of the intervention, some children complained about 
stomachache after ingestion of the iron. The frequency of gastrointestinal 
side effects is known to relate to the iron dose, but also symptoms were 
most common in pupils who came to school without breakfast. 
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CHAPTER Six 
DISCUSSION AND CONCLUSION 
6.1- Discussion: 
Despite the best efforts, only about 56 children of 72 were reevaluated 
after the three months as shows in table 2 and figure 1, and this was due 
to movement from the centers or had become ill. 
Table 3 and figure 2 showed that most of the study population were male 
(64%) and female were about 36%. 
The study showed that the prevalence of anemia in the study group was 
about (60%) as described in table 4 and figure 3, and this was high than 
the prevalence of anemia of preschoolers over the world(43%)(46). But 
this was less than the prevalence of anemia in Sudanese preschoolers 
(84.6%) (47), and this is possibly due to the high economic level of 
Dongola city compared with other areas of northern Sudan. 
Table 5(a), table 5(a) and figure 4 showed that the prevalence of anemia 
in female was 60% and male was 55%. 
Table 7 and figure 5 showed that the mean body weights of the study 
group were less than the ideal body weight for each age.  
Also the study showed that as described in table 8, figure 6, table 9, 
figure 7, table 10 and figure 8 there was an increase in hemoglobin levels 
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in all children.  After three months of weekly doses there was a mean 
increase of 8 g/l. This significant  improvement reduced prevalence of 
anemia by more than 50%, in only three months, the prevalence of 
anemia reduced from 57.1 % to 28% in the total sample, and tended to 
control and prevent the deficiency, depending on compliance. This 
reduction to more than half the initial prevalence  agrees with weekly iron 
supplementation studies in preschool children conducted in Brazil(56, 57) 
in which the prevalence reduced by 66.5%, and in other developing 
countries; Indonesia(52), Vietnam (58)and Bolivia(59). The pioneering 
study with Chinese preschool children(51)showed that the correction of 
hemoglobin levels attained 100%  
Table 9 and figure 7 showed that the initial hemoglobin level of 5 years 
old children was higher (110.6g/l) than that of 4years and 3 years (104.5, 
106g/l) respectively, this may be due to that 5 years old are self 
dependent and they eat better. 
Table 10 and figure 8 showed that the rate of changes of hemoglobin as 
expected, the greatest change was observed among the most anemic 
children, this expectation was due to improved iron uptake when the body 
lacks mineral(60). This strongly suggests that the main cause of the low 
hemoglobin levels is iron deficiency. By the 12th week of 
supplementation the more anemic children were still increasing their 
56 
 
hemoglobin levels, by 0.9g/l for each dose of ferric ingested, suggesting 
that a longer period of supplementation could be beneficial (64).   
Table 11 and figure 9 showed that there was a variation in responsiveness 
of female and male to weekly iron supplementation, the prevalence of 
anemia in female  dropped from 60% to 25% and from 55% to 31% in 
male.   
The present study provided iron doses of approximately 6 mg/kg 
weight/week, the same used in Brazilian school children(57)with 
difference in the period of study ( three months vs. four months in 
Brazilian study) which was reduced the prevalence by 66.5%, also same 
dose used in the pioneer work of Liu et al(51). This was enough for 
eliminating anemia at less than 3 years old, even for those < 100 g Hb/l. It 
was also higher than the dose used by Schultinket al.(52), Thu et 
al.(58)and Monteiro et al.(56). So, the iron dosage level is by far adequate 
to control and, consequently, prevent anemia. 
Compared to the study conducted in Indonesia the present study results 
were even more conclusive because the Indonesian children were 
dewormed prior to the supplementation, changes in hemoglobin levels 
could be due to in part to deworming. In Indonesian study the iron 
supplementation lasted only eight weeks and the changes in hemoglobin 
concentration were 7g/l for the group receiving a twice-weekly 
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supplementation of 4mg/kg. In Chinese study, changes in Hb conc. were 
26.7g/l with same dose of our study and the same period of 
supplementation.    
While a closed comparison between the above studies is not feasible due 
to differences in iron dose, duration of the supplementation period, initial 
hemoglobin level and environmental settings, the findings from these 
studies agree on the similar efficacy of an intermittent iron 
supplementation.    
The strategy of long term weekly supplementation in preschool children 
should lead, primarily, to the prevention of iron deficiency anemia 
including the progressive accumulation of adequate iron reserves which 
will insure protection from iron deficiency later in life, during 
adolescence and in the case of women, during their reproductive life. The 
study of Liu et al (1995b) showed the safety and excellent tolerance of 
the weekly dose. 
Several issues need further attention. Although the prevalence of anemia 
was markedly reduced, 28% of the children remained anemic after 12 wk 
of supplementation. Whether a prolonged period of supplementation 
would be beneficial to further reduction of prevalence of anemia, or 
whether the treatment needs to be modified such that other 
micronutrients, such as vitamin A(61, 62), be added to improve the 
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treatment effect needs to be investigated. Furthermore, the current 
intervention was aimed at children aged 3-5 y; however, the population 
group most at risk of iron deficiency is infants aged 6-12 months. These 
children depend completely on diet for iron because their iron stores are 
low or depleted and their iron requirement is very high because of their 
rapid growth rate(63). The diet of many infants in developing countries 
contains an insufficient amount and quality of iron; therefore, weekly 
supplementation may provide them with sufficient iron to prevent 
deficiency. 
 
6.2. Conclusion: 
The results of this study showed that the weekly iron supplementation has 
significant effect on hemoglobin status especially in severe anemic 
children (Hb less than 95 g/l), and reduced the prevalence of anemia by 
50% in pre-school children of Dongola city and are in agreement with 
other studies realized in very different environments.  These findings 
could lead to a revision of iron supplementation strategies for the 
prevention and control of iron deficiency and anemia if the global 
effectiveness of such a strategy is proven: compliance by the children and 
cooperation of school staff and/or community members in field 
conditions under the supervision of national and local health authorities. 
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The mothers were able to improve the iron status of their children through 
once-weekly supplementation after having received clear instructions. 
Improvement in iron status may be achieved through home 
supplementation without the classic intervention efforts of the health 
sector. 
We conclude that once-weekly iron supplementation was an effective, 
cheap, and simple intervention that improved iron status in preschoolers 
in Dongola city. The treatment caused no side effects and involved little 
chance of overdose. Once the iron status of these children is restored, 
chances are favorable that it will remain adequate for a prolonged period 
of time(64). 
 
6.3. Recommendations  
We recommend that, there must be a committed health professionals 
aware of the importance of the treatment and of preventing anemia in 
children in the risk group, regardless of whether they are in kindergartens 
or part of routine public health programs. 
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Annexes  
Record form 
1-Kindergarten’s name ……………………………………………… 
2-Child name …………………………………………………… 
3-Initial age of child ………………………………………… 
4-Intial body weight of child …………………………………………. 
5-Initial hemoglobin concentration (Hb0) …………………………….. 
6-Dose of ferrous sulphate in (ml) / week ……………………………… 
7-Hemoglobin concentration after the intervention……………………. 
………………………………………………………………………….. 
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  ﺮارــــــــــــﻗاﻻ
 :إﻗﺮار اﻟﻤﺸﺎرك 
 ﺗﻢ ﺷﺮﺣﻬﺎ ﻟﻲ وأﺗﻴﺢ ﻟﻰ ﻃﺮح اﻷﺳﺌﻠﺔ ﻋﻨﻬﺎ آﻴﻔﻤﺎ ﺷﺌﺖ ﻟﻘﺪ إﻃﻠﻌﺖ ﻋﻠﻰ اﻟﻤﻌﻠﻮﻣﺎت اﻟﺤﺎﻟﻴﺔ واﻟﺘﻲ
و أﻧﺎ أﻗﺮ ﻋﻦ اﺑﻨﻰ ﺑﺎﻟﻤﻮاﻓﻘﺔ  ﻋﻠﻰ اﻟﻤﺸﺎرآﺔ , ﻗﺪ ﺗﻠﻘﻴﺖ اﻹﺟﺎﺑﺎت اﻟﻮاﻓﻴﺔ ﻋﻦ آﻞ اﻷﺳﺌﻠﺔ و
ﻓﻰ هﺬﻩ اﻟﺪراﺳﺔ  و أﻋﻠﻢ ﺑﺤﻘﻰ ﻓﻰ اﻟﺘﻮﻗﻒ ﻋﻦ اﻟﻤﺸﺎرآﺔ ﻓﻰ أى وﻗﺖ دون أن ﻳﺆﺛﺮ  ﻃﻮاﻋﻴﺔ
( .                                            ﺒﻴﺔ اﻟﻼزﻣﺔ ﻓﻰ أى وﻗﺖ ﻻﺣﻘًﺎ  ﺗﻠﻘﻰ اﻟﻌﻨﺎﻳﺔ اﻟﻄ: ﻣﺜًﻼ ) ذﻟﻚ ﻋﻠﻰ ﺣﻘﻮﻗﻰ ﻓﻰ 
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  ........................................................................................ : اﻟﻤﺸﺎرك ﻮﻟﻰ اﻣﺮإﺳﻤ
  ......................................................................................: اﻟﻤﺸﺎرك وﻟﻰ اﻣﺮﺗﻮﻗﻴﻊ 
  ................................................:........................ﺗﻮﻗﻴﻊ  ﻣﻦ ﻳﻨﻮب ﻋﻦ اﻟﻤﺸﺎرك ﺷﺮﻋَﺎ
  ...............................................................:................ ﻋﻨﻮان ﻣﻦ ﻳﻨﻮب ﻋﻦ اﻟﻤﺸﺎرك
  :ﻓﻲ ﺣﺎل ﻋﺪم ﻗﺪرة  وﻟﻰ اﻣﺮ اﻟﻤﺸﺎرك ﻋﻠﻰ ﻗﺮاءة اﻹﻗﺮار وﻳﺤﺘﺎج إﻟﻰ ﻣﻦ ﻳﺸﺮح أو ﻳﺘﺮﺟﻢ ﻟﻪ 
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  ........................................................(: ...........................اﻟﻤﺘﺮﺟﻢ) ﺗﻮﻗﻴﻊ اﻟﺸﺎرح أو
  : ..................................................................................................ﺗﻮﻗﻴﻊ اﻟﺒﺎﺣﺚ
 
 
 
74 
 
 
1. (WHO). nutritional anemias. genebra: WHO Scientific group1968. 
2. Johnson SR WM, Boyce WT, Broadwin R, Mclaughlin R & Goldman L. the 
association between hemoglobin and behavior problems in a sample of low-income 
hispanic preschool children. Devbevav pediatr1992;13:209-14. 
3. Walter T kJSA. Effect of mild iron deficiency on infant mental development 
scores. peddiatr 1983;102:519- 22. 
4. pollitt E, Saco-pollitt C, Leibel RL&Viten E. Iron deficiency and behavioral 
development in infants and preschool children. AM, J CLIN nutr 1986;43;:555-65. 
5. Lozoff B JEWA. Long-term developmental outcome of infants with iron 
deficiency. wen Engl J Med1991;325:687-94. 
6. SJ F-T. Iron deficiency in infancy; easy to prevent or is it not? . Eur J Clin 
Nutr1992;46:9-14. 
7. Angeles  I, Schultink WJ, Matulessi P, Gross R& Sastroamidjojo. decreased 
rate of stunting among anemic indonesian preschool children through iron 
supplementation. . Am  J CLIN NUP1993;58:339-42. 
8. E. VF. Iron deficiency. in:  proceedings of ending hidden hunger. montereal, 
Quebec, Canadaoctober1991:10-2. 
9. De Agelis RC CM. Bioavailability of iron in infant feeding. Themes of 
Pediatrics 52 Nestle, scientific information service1993. 
10. Bottoni C, Schimitz BAS, Campanaro '', Accioly and Cuvello LCF. . Anemia. 
paul pediatr1997;15:127-34. 
11. Wolde-Gebriel Z WC, Gebru H, Tadesse AS, Fisseha T, 
Gabre P et al. Interrelationship between vitamin A, iodine, and 
iron status in schoolchildren in Shoa region, Central Ethiopia. Br 
J Nutr 1993;70:593-607. 
12. PR D. deficiency in the wealing: a nutritional problem on 
way to resolution. Acta Paediatric Scand 1985;323:59-67. 
13. (US). NRC. Recommended Dietary Allowances. In: RDA. 
SoTEot, editor. National Academy of Sciences;1989. 
14. Souza Queiroz S TM. Anemia: ferropriva Physiopathological aspects and 
experience with the use of milk fortified with iron. . Ped Mod1995;31:441-55. 
15. Suzana de Souza Queiroz mAdATi. deficiency anemia in 
children. journal pediatria200;76:298-304. 
16. Queiroz Sde S, Torres MA. [Iron deficiency anemia in children]. J Pediatr 
(Rio J)2000 Nov;76 Suppl 3:S298-304. 
17. Layrisse M M-TC, Roche M. . The effects of interaction of 
various foods on iron absorption. Am J Clin Nutr1968;11:1175-83. 
18. Hierro DP. Current knowledge about nutrition. . Washington. 
PAHO/who; 1991. 
19. Beard JL DH, Pinero DJ. . iron metabolism: a 
comprehesive review. Nutr Rev 1996;54:295-317. 
75 
 
20. Rivera F WT. Anemia ferropriva the lactente and psychological school 
development. J pediatr (Rio J) 1997;73(10):s49-s54. 
21. PR. D. Nutritional anemias. Rudolph AM PEDIATRICS:Appleton and lange, 
1991:1091-106. 
22. Nóbrega FJ AF. Nutritional Disorders and weak link mother/filho. . Rio de 
Janeiro: Revinter; 1996. . 
23. 1. Ioli JGSLM. Primary health care of infants, children, & adolescents Anemia In JA 
Fox (Ed), (2002);(2nd ed.):(pp. 471-80). 
24. 1. Lesperance L, Wu, A.C., & Bernstein, H.   . Putting a dent in iron deficiency. 
Contemporary Pediatrics, (2002).19((7)):, 60-79. 
25. Tender J, & Cheng, T.L. .  Gellis & Kagan's current , , editors. Iron deficiency anemia. In 
F.D. Burg., J.R. Ingelfinger, R.A. Polin, & A.A. Gershon (Eds.),. Philadelphia: W.B. Saunders(2002). 
26. 1. Zlotkin S, Arthur, P., Antwi, K.Y., & Yeung, G. . Randomized, controlled trial of 
single versus 3-times-daily ferrous sulfate drops for treatment of anemia. . Pediatrics, (2001). ;108( 
(3),): 613-6. 
27. 1. Abshire TC. Sense and sensibility: Approaching anemia in children. Contemporary 
Pediatrics,(2001);18((9),):104-13. 
28. PR D. Anemia of prematurity. Advances in 
Pediatrics;Vol.  199:385-400. 
29. Shah N LM, Bardekar SB editor. Iron deficiency in India. 
New Delhi,  
: Jaypee Brothers.; 2000. 
30. . RGMN, :   J, 7. POisonings: Drugs. chemical 
and plants. 16th edn.  
 ed. Textbook ofPediatrics, editor. Philadelphia WB Saunders Company,: In : Behrman RE, Kliegmann RM, Jenson HH 
(eds) Nelson 2000. 
31. S. G. Pediatric Hematology. 9th edn ed. (ed) IGS, editor. New DeIhl. : Jaypee 
Brothers; 2001  
32. Schwartz E, . Anemias of Inadequate production ln Behrman RE, Kliegmann 
RM Jenson HB (eds). 16th edn 
 ed. Philadelphia \W B: Saunders Company:; 2000  
33. KapiI G AA. Iron defiCiency anemia In' Gupte S (ed) Recent Advanccs in 
Pediatrics New Delhi: : Jaypee Brothers  1998. 
34. De Maeyer EM DP, Gurmay 1M, Hallbug L, Sood, SK SS. Preventing 
and controlling iron deficiency anaemia through primary health 
care. . geneva: WHO;; 1989. . 
35. Lutter CK RA, Fuenmayor G, Avila L, Sempertegui F, Escobar J. Growth and 
micronutrient status among children receiving a fortified complementary food. J 
Nutr2008;138:379-88. 
36. Rivera JA S-AD, Habicht JP, Shamah T, Villalpando S. Impact of the 
Mexican program for education, health, and nutrition (Progresa) on rates of growth 
and anemia in infants and young children: A randomized effectiveness study. 
JAMA2004;291:2563-70. 
37. Olivares M. T W HE, Pizarro F, Stekel A. Prevention of iron deficiency by 
milk fortification. The Chilean experience. Acta Paediatr Scand Suppl 1989;361:109-
13. 
76 
 
38. Torrejón CS D-CC, Hertrampf E, Ruz M. Zinc and iron nutrition in Chilean 
children fed fortified milk provided by the Complementary National Food Program. 
Nutrition 2004;20:177-80. 
39. Dewey KG A-AS. Systematic review of the efficacy and effectivness of 
complementary feeding interventions in developing  
countries. Matern Child Nutr2008;4:24-85. 
40. Adu-Afarwuah S LA, Brown KH, Zlotkin S, Briend A, Dewey KG. Home 
fortification of complementary foods with micronutrient supplements is well accepted 
and has positive effects on infant iron status in Ghana. Am J Clin Nutr2008;87:929-
38. 
41. Adu-Afarwuah S LA, Brown KH, Zlotkin S, Briend A, Dewey KG. 
Randomized comparison of 3 types of micronutrient supplements for home 
fortification of complementary foods in Ghana: Effects on growth and motor 
development. Am J Clin Nutr2007;86:412-20. 
42. Christofides A AK, Schauer C, Sharieff W, Owusu-Agyei S, Zlotkin S. Multi-
micronutrient Sprinkles including a low dose of iron provided as microencapsulated 
ferrous fumarate improves haematologic indices in anaemic children: a randomized 
clinical trial. Matern Child Nutr2006;2:169-80. 
43. Zlotkin S AK, Schauer C, Yeung G. Use of microencapsulated iron(II) 
fumerate sprinkles to prevent recurrence of anemia in infants and young children at 
high risk. Bull World Health Organ2003;81:108-15. 
44. Menon P RM, Loechl C, Arimond M, Habicht JP, Pelto G. Micronutirent 
Sprinkles reduce anemia among 9- to 24-mo-old children when delivered through an 
integrated health and nutrition program in rural Haiti. J Nutr2007;137:1023-30. 
45. R. Y. The epidemiology of childhood iron deficiency: 
evidence for improving iron nutrition among US children.  
Brain, behavior and iron in the infant diet. In: Dobbing J, ed. ed. 
R. Y, editor. Virginia (USA): . Springer-Verlag;; 1992. 
46. CA. F, . Iron nutrition: food and nutrition in health and 
disease. Ann NY Acad Sci ;1977;300::221.,. 
47. al EAe. Endemic goiter with iodine sufficiency: a 
possible role for the consumption of pearl millet in the 
etiology of endemic goiter. . American Journal of 
Clinical Nutrition, 2000;71 ((1)):59-66. Ref 1553. 
48. GP. BGM. Efficacy of intermittent iron supplementation in 
the control of iron deficiency anaemia in developing countries: . 
Toronto:: GHB Consulting;1999. 
49. Viteri FE HS, Galán P, Guiro A & Preziosi P   In: . . 
Absorption of iron supplements administered daily or weekly, a 
collaborative study. Nestle Foundation for the Study of the 
Problems of Nutrition in the World(1994)::Annual report 82-96. 
50. NW S. Competitive interaction of iron and zinc in the diet. J 
Nup1986;116(Consequences for human nutrition. ): 927-35. 
77 
 
51. Liu XN KJ, Zhao L & Viteri FE  Intermittent iron 
supplementation in chinese preschool children is efficient and 
safe. Food Nut Bull (1995b);16(2):139-46. 
52. Schultink W GR, Gliwitzlci M, Karjadi D & Matulessi P 
Effect of daily vs twice week iron supplementation in 
Indonesian preschool children with low iron status. Am J Clin 
Nutr (1995);61:111-5. 
53. DaSilva. GSBPTMSM. weekly iron supplementation in preschool children. 
Cuiaba: federal University of Mato Grosso, Brazil; june 2004. 
54. Longfils P, Heang, U. K., Soeng, H. and Sinuon, M. , . Weekly Iron and Folic Acid 
Supplementation As a Tool to Reduce Anemia among Primary School Children in Cambodia. 
Nutrition Reviews2005;63:s139-s45. 
55. Faqih AM KS, Izzat M .    . Effect of weekly iron 
supplementation in  Jordian preschool children. Amman, 
Jordan.: University of Jordan,; 2005. 
56. Monteiro CA SS, Brunken GS, Gross R & Conde WL.     . 
Long-term preventive mass prescription of weekly doses of iron 
sulfate may be highly effective to reduce endemic child anemia. 
Food Nutr Bull2000a;22::53-61. 
57. Ferreira MLM FL, Silva AA & Batista-Son m. . Effectiveness of application 
of ferrous sulphate in doses downloads in family health Programme in Caruaru,. 
PERNAMBUCO Cad ;:  public health 2003;19:375-81. 
58. Thu BD SW, Dillon DD, Gross R, Leswara ND & Khoi 
HH., . Effect of daily and weekly micronutrient supplementation 
on micronutrient deficiencies and growth in young Vietnamese 
children. Am J Clin Nutr 1999;;69::80-6. 
59. Berger J AV, Téllez W, Luján C, Traissac P & San Miguel 
JL. , . Weekly iron supplementation is as effective as 5 day per 
week iron supplementation in Bolivian school children living at 
high altitude. Eur J Clin Nutr ;1997;51::381-6. 
60. Brault-Dubuc M NMDJ. Iron status of French-Canadian children: a three-year follow-up 
study. Hu Nutrition: Appl Nutr 1983;37:210-21. 
61. MejIa LA CF. Hematological effect of supplementing anemic children with 
vitamin A alone and in combination with iron. Am J Clin Nutr1988;48:595-600. 
62. Bloem MW WM, van Agtmaal El, Speck AJ, Saowakontha 5,Schreurs WHP. 
Vitamin A intervention: short-term effects of a single,oral, massive dose on iron 
metabolism. Am J Clin Nutr 1990;51:76-9. 
63. Dallman PR SM, Stekel A. Iron deficiency in infancy andchildhood. Am J 
Clin Nutr 1980;33:86-118. 
64. Angeles IT GR, Schultink W, Sastroamidjojo S. Is there a long-term effect of 
iron supplementation on anemia alleviation? Am J Clin Nutr1995;62:440-1. 
 
78 
 
 
